ERISNSEERIS LIFESCIENCES LIMITED· Pharmaceuticals & BiotechnologyHighNegative
Announced Mon, 5 Oct, 2026 · 11:59 IST

Executive Director and COO Krishnakumar Vaidyanathan resigns from Eris Lifesciences

Kmp ResignedManagement Changes View source PDFExplain this filing

ERIS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.8%Reaction day
₹1190.20
prior close
₹1185.70
announcement price
In-mkt
timing
Nifty Smallcap 250market+0.4%-1.1% vs market
Pharmaceuticals peers, median of 173sector-0.7%-0.1% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Smallcap 250 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
-0.5
30m
-0.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.8+0.4-1.1-0.7-0.1
Next day
-0.2+1.8-1.9+0.6-0.8
2d
-3.8+1.9-5.7+0.4-4.2
3d
-2.4-0.6-1.8-2.3-0.1
4d
-2.2-0.1-2.1-2.1-0.1
5d
-3.2+1.0-4.2-2.5-0.7
1w
-3.5+1.4-4.9-2.4-1.1
15d
-0.1-3.7+3.6-4.4+4.3
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr Krishnakumar Vaidyanathan has resigned as Executive Director and Chief Operating Officer of Eris Lifesciences with effect from close of business on September 30, 2026. He stated he is leaving to pursue professional opportunities outside the company. The board accepted his resignation and waived the notice period.

Likely market impact

Loss of a key managerial person; may raise succession and operational continuity concerns among investors.